Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Anthony Hayes Insider Profile
4 Followers
Anthony Hayes, CEO, Director at AIkido Pharma, holds 1.13M shares in Hoth Therapeutics (Ticker: HOTH), holds 52.18K shares in AIkido Pharma (Ticker: AIKI). Most recently, Anthony Hayes Sold ― shares of Hoth Therapeutics on May 29, 2020 for an estimated value of 500.00K.
Profitable Transactions
5 out of 8 Profitable Transactions
Average Return
-15.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Anthony Hayes holds in companies
Most Profitable Insider Trade
The most profitable trade made by Anthony Hayes
Anthony Hayes's Trading History
AIkido Pharma
Nov 20, 2018
CEO, Director
Informative Buy
8.84K
$26.61K
Hoth Therapeutics
May 29, 2020
Ten Percent Owner
Informative Sell
500.00K
$1.91M
List of latest transactions for each holding click on a transaction to see Anthony Hayes's performance on stock
You May Also Like
Anthony Hayes insider profile FAQ
What is the percentage of profitable transactions made by Anthony Hayes?
The percentage of profitable transactions made by Anthony Hayes is 63%.
What is the average return per transaction made by Anthony Hayes?
The average return per transaction made by Anthony Hayes is -15.70%.
What stocks does Anthony Hayes hold?
Anthony Hayes holds: AIKI, HOTH stocks.
What was Anthony Hayes’s latest transaction?
Anthony Hayes latest transaction was an Informative Sell of $500.00K.
What was Anthony Hayes's most profitable transaction?
Anthony Hayes’s most profitable transaction was an Informative Sell of HOTH stock on May 29, 2020. The return on the trade was 41.50%.
What is Anthony Hayes's role in AIkido Pharma?
Anthony Hayes's role in AIkido Pharma is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.